Episode 27 - Nathan Clark And 10% Faster To The Market With Digitalization The Future Of Pharma podcast

Innhold levert av Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

The Future of Pharma »
Episode 27 - Nathan Clark and 10% Faster to the Market with Digitalization

6d ago 41:38

Del

MP3•Episoder hjem

My guest in this episode is Nathan Clark.

Nathan is the Co-Founder of Ganymede.bio, one of the fastest-growing software startups in biotech. Ganymede is the modern, data platform for life sciences companies, and its focused on integrating physical lab instruments with digital workflows. Prior to Ganymede, Nathan was the product manager at Benchling for Machine Learning and Insights Analytics. He also has a background in financial technology and trading, and notably launched affirm.com/savings.

In this informative talk, Nathan and I talked about - His journey from being a bond trader to a life science data entrepreneur, - Difference between Fintech and life science tech - How Genymede is doing it differently than the other companies - How to be 10% faster to the market with new drugs - Growing with a remote working team - Why he got into a life science start up - His fondness for MIT Open Courseware

You can reach out to him by email, his website or LinkedIn.

I enjoyed my chat with Nathan. Hope you do too.

28 episoder

#Science #Fitness #Medicine #Samir Gondalia, ISPE Boston #ISPE Boston #Samir Gondalia #Boston #Gondalia #Healthcare #Innovation #Ispeboston #Pharma #Pharmaceutical #ISPE